Skip to main content

Advertisement

Log in

Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis induction

  • Paper
  • Published:
Photochemical & Photobiological Sciences Aims and scope Submit manuscript

Abstract

Toluidine blue (TBO) is a cationic thiazine dye with an affinity for neoplastic tissues in vivo. The objective of this study was to explore the in vitro photosensitizing potential of TBO and its capacity to induce apoptosis in human leukaemic T cells. Jurkat cells were incubated with TBO for one hour followed by exposure to 11 J cm-2 of visible light from a slide projector. Cytotoxicity was assessed at 24 hours using a MTT assay. DNA fragmentation was examined at different intervals after photodynamic treatment using a DNA elution-filtration assay with [14C]- thymidine labelled cells. Caspase-3 like activation induced by photodynamic treatment was studied by measuring AC-DEVD-AMC peptide hydrolysis. The MTT assay showed a 97% decrease in optical density 24 hours following photodynamic therapy with 0.15 μg m-11 of TBO. Dark toxicity was absent under these conditions. DNA fragmentation was detected as early as 2 hours after photodynamic therapy and reached 68% at 6 hours. At higher TBO concentrations less DNA fragmentation and more dark toxicity was observed. An increase in caspase-3 like activity was also induced by photodynamic therapy with TBO. At the time of light exposure TBO was present in the endoplasmic reticulum and Golgi regions. In conclusion, TBO-based photodynamic therapy has a potent phototoxic effect and induces apoptosis in Jurkat cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. J. S. McCaughan, Photodynamic therapy: a review, Drugs Aging, 1999, 15, 49–68.

    Article  CAS  Google Scholar 

  2. C. H. Sibata, V. C. Colussi, N. L. Oleinick and T. J. Kinsella, Photodynamic therapy in oncology, Expert. Opin. Pharmacother., 2001, 2, 917–927.

    Article  CAS  Google Scholar 

  3. M. Wilson and N. Mia, Sensitization of Candida albicans to killing by low-power laser light, J. Oral. Pathol. Med., 1993, 22, 354–357.

    Article  CAS  Google Scholar 

  4. M. Wilson, T. Burns, J. Prattent and G. Pearson, Bacteria in supragingival plaque samples can be killed by low-power laser light in the presnece of a photosensitizer, J. Appl. Bacteriol., 1995, 78, 569–574.

    Article  CAS  Google Scholar 

  5. M. Wilson and C. Yanni, Killing of methicillin-resistant staphylococcus aureus by low-power laser light, J. Med. Microbiol., 1995, 42, 62–66.

    Article  CAS  Google Scholar 

  6. J. L. Williams, J. Stamp, R. Devonshire and G. J. Fowler, Methylene blue and the photodynamic therapy of superficial bladder cancer, J. Photochem. Photobiol. B, 1989, 4, 229–232.

    Article  CAS  Google Scholar 

  7. G. Fowler, R. Rees and R. Devonshire, The photokilling of bladder carcinoma cells in vitro by phenothiazine dyes, Photochem. Photobiol., 1990, 52, 489–494.

    Article  CAS  Google Scholar 

  8. P. Herlin, J. Marnay, J. H. Jacob, J. M. Ollivier and A. M. Mandard, A study of the mechanism of the toluidine blue dye test, Endoscopy, 1983, 15, 4–7.

    Article  CAS  Google Scholar 

  9. Y. Eliezri, The toluidine blue test: an aid in the diagnosis and treatment of early squamous cell carcinomas of mucous membranes, Journal of the American Academy of Dermatology, 1988, 18, 1339–1349.

    Article  CAS  Google Scholar 

  10. J. B. Epstein, C. Oakley, A. Millner, S. Emerton, E. van der Meij and N. Le, The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma, Oral Surg. Oral Med. Oral Pathol., 1997, 83, 537–547.

    Article  CAS  Google Scholar 

  11. I. Martin, C. Kerawala and M. Reed, The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontics, 1998, 85, 444–446.

    Article  CAS  Google Scholar 

  12. R. L. Miller, B. W. Simms and A. R. Gould, Toluidine blue staining for detection of oral premalignant lesions and carcinomas, J. Oral Pathol., 1988, 17, 73–78.

    Article  CAS  Google Scholar 

  13. J. Lundgren, J. Olofsson and H. Hellquist, Toluidine blue. An aid in the microlaryngoscopic diagnosis of glottic lesions?, Arch. Otolaryngol., 1979, 105, 169–174.

    Article  CAS  Google Scholar 

  14. M. S. Strong, C. W. Vaughan and J. Incze, Toluidine blue in diagnosis of cancer of the larynx, Arch. Otolaryngol., 1970, 91, 515–519.

    Article  CAS  Google Scholar 

  15. J. Tarkkanen, M. Paavolainen and E. Saksela, Toluidine blue staining in the endoscopic diagnosis of carcinoma of the bronchus, Ann. Clin. Res., 1972, 4, 7–9.

    CAS  Google Scholar 

  16. K. A. Warnakulasuriya and N. W. Johnson, Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer, J. Oral Pathol. Med., 1996, 25, 97–103.

    Article  CAS  Google Scholar 

  17. A. Mashberg, Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III, Cancer, 1980, 46, 758–763.

    Article  CAS  Google Scholar 

  18. A. McHale and L. McHale, Use of tetrazolium-based colorimetric assay for assessing photoradiation therapy in vitro, Cancer Lett., 1988, 41, 315–321.

    Article  CAS  Google Scholar 

  19. R. Bertrand and Y. Pommier, in Cell growth and apoptosis; A practical approach. ed. G. P. Studzinski, IRL Press, New York, 1995, pp. 97–118.

  20. R. Bertrand, M. Sarang, J. Jenkin, D. Kerrigan and Y. Pommier, Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression, Cancer Res., 1991, 51, 6280–6285.

    CAS  Google Scholar 

  21. A. T. Sane and R. Bertrand, Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities, Cancer Res., 1998, 58, 3066–3072.

    CAS  Google Scholar 

  22. M. Garcia-Calvo, E. P. Peterson, D. M. Rasper, J. P. Vaillancourt, R. Zamboni, D. W. Nicholson and N. A. Thornberry, Purification and catalytic properties of human caspase family members, Cell Death Differ., 1999, 6, 362–369.

    Article  CAS  Google Scholar 

  23. M. Wainwright, Non-porphyrin photosensitizers in biomedicine, Chem. Soc. Rev., 1996, 2, 351–358.

    Article  Google Scholar 

  24. Z. Darzynkiewicz and S. P. Carter, Photosensitizing effects of the tricyclic heteroaromatic cationic dyes pyronin Y and toluidine blue O (tolonium chloride), Cancer Res., 1988, 48, 1295–1299.

    CAS  Google Scholar 

  25. N. S. Soukos, M. Wilson, T. Burns and P. M. Speight, Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro, Lasers Surg. Med., 1996, 18, 253–259.

    Article  CAS  Google Scholar 

  26. F. Gad, G. Viau, M. Boushira, R. Bertrand and R. Bissonnette, Photodynamic therapy with 5-aminolevulinic acid induces apoptosis and caspase activation in malignant T cells, Journal of Cutaneous Medicine and Surgery, 2001, 5, 8–13

    Article  CAS  Google Scholar 

  27. M. Dellinger, Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol, Photochem. Photobiol., 1996, 64, 182–187.

    Article  CAS  Google Scholar 

  28. Y. Miyamoto, Y. Umebayashi and T. Nishisaka, Comparison of phototoxicity mechanism between pulsed and continuous wave irradiation in photodynamic therapy, J. Photochem. Photobiol. B, 1999, 53, 53–59.

    Article  CAS  Google Scholar 

  29. D. Kessel, Y. Luo, Y. Deng and C. K. Chang, The role of subcellular localization in initiation of apoptosis by photodynamic therapy, Photochem. Photobiol., 1997, 65, 422–426.

    Article  CAS  Google Scholar 

  30. S. R. Wood, J. A. Holroyd and S. B. Brown, The subcellular localization of Zn(II) phthalocyanines and their redistribution on exposure to light, Photochem. Photobiol., 1997, 65, 397–402.

    Article  CAS  Google Scholar 

  31. N. S. Trivedi, H. W. Wang, A. L. Nieminen, N. L. Oleinick and J. A. Izatt, Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy, Photochem. Photobiol., 2000, 71, 634–639.

    Article  CAS  Google Scholar 

  32. G. G. Miller, K. Brown, A. M. Ballangrud, O. Barajas, Z. Xiao, J. Tulip, J. W. Lown, J. M. Leithoff, M. J. Allalunis-Turner, R. D. Mehta and R. B. Moore, Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update, Photochem. Photobiol., 1997, 65, 714–722.

    Article  CAS  Google Scholar 

  33. A. J. Dunipace, R. Beaven, T. Noblitt, Y. Li, S. Zunt and G. Stookey, Mutagenic potential of toluidine blue evaluated in the Ames test, Mutat. Res., 1992, 279, 255–259.

    Article  CAS  Google Scholar 

  34. J. Y. Matroule, C. M. Carthy, D. J. Granville, O. Jolois, D. W. Hunt and J. Piette, Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methyl ester photosensitization, Oncogene, 2001, 20, 4070–4084.

    Article  CAS  Google Scholar 

  35. W. L. Rumboltz, C. F. Moon, J. C. Novelli and A. B. Omaha, Use of protamine sulfate and toluidine blue for abnormal uterine bleeding, Am. J. Obstet. Gynecol., 1952, 63, 1029–1037.

    Article  Google Scholar 

  36. C. A. Lathrop and W. T. Carlisle, Oral toluidine blue in the treatment of hypermenorrhea, Am. J. Obstet. Gynecol., 1952, 64, 1376–1377.

    Article  CAS  Google Scholar 

  37. W. Bickers, Toluidine blue-An evaluation in the treatment of uterine bleeding, Am. J. Obstet. Gynecol., 1953, 66, 1313–1317.

    Article  CAS  Google Scholar 

  38. R. J. Hurvitz, S. L. Perzik and L. Morgenstern, In vivo staining of the parathyroid glands. A clinical study, Arch. Surg., 1968, 97, 722–726.

    Article  CAS  Google Scholar 

  39. R. M. Yeager and E. T. Krementz, Toluidine blue in identification of parathyroid glands at operation, Ann. Surg. (Chicago), 1969, 169, 829–838.

    Article  CAS  Google Scholar 

  40. R. E. Moe and P. J. Klopper, Demonstration of the functional anatomy of the canine gastric antrum. II. Operative technics not requiring gastrotomy, Am. J. Surg., 1966, 111, 80–88.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge advice and suggestions provided by Dr Richard Bertrand. This work was funded by the University of Montreal Hospital Center Foundation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tremblay, JF., Dussault, S., Viau, G. et al. Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis induction. Photochem Photobiol Sci 1, 852–856 (2002). https://doi.org/10.1039/b204385h

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1039/b204385h

Navigation